These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21593043)

  • 1. DHEA as a miracle drug in the treatment of poor responders; hype or hope?
    Yakin K; Urman B
    Hum Reprod; 2011 Aug; 26(8):1941-4. PubMed ID: 21593043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis.
    Narkwichean A; Maalouf W; Campbell BK; Jayaprakasan K
    Reprod Biol Endocrinol; 2013 May; 11():44. PubMed ID: 23680224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of dehydroepiandrosterone in reproduction: A review of the evidence.
    Lin LT; Tsui KH; Wang PH
    J Chin Med Assoc; 2015 Aug; 78(8):446-53. PubMed ID: 25708822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.
    Nagels HE; Rishworth JR; Siristatidis CS; Kroon B
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009749. PubMed ID: 26608695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
    Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
    Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation.
    Gleicher N; Weghofer A; Barad DH
    Reprod Biomed Online; 2010 Sep; 21(3):360-5. PubMed ID: 20638339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
    Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
    J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserve and is a potential regulator of the immune response in the ovaries.
    Zhang J; Qiu X; Gui Y; Xu Y; Li D; Wang L
    Biosci Trends; 2015 Dec; 9(6):350-9. PubMed ID: 26781792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHEA for poor responders: can treatment be justified in the absence of evidence?
    Urman B; Yakin K
    Reprod Biomed Online; 2012 Aug; 25(2):103-7. PubMed ID: 22717246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
    Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
    Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency.
    Yeung TW; Li RH; Lee VC; Ho PC; Ng EH
    J Clin Endocrinol Metab; 2013 Jan; 98(1):380-8. PubMed ID: 23144466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does dehydroepiandrosterone have any benefit in fertility treatment?
    Urman B; Yakin K
    Curr Opin Obstet Gynecol; 2012 Jun; 24(3):132-5. PubMed ID: 22327737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
    Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
    Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
    Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders.
    Sönmezer M; Ozmen B; Cil AP; Ozkavukçu S; Taşçi T; Olmuş H; Atabekoğlu CS
    Reprod Biomed Online; 2009 Oct; 19(4):508-13. PubMed ID: 19909591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dehydroepiandrosterone on in vivo ovine follicular development.
    Narkwichean A; Jayaprakasan K; Maalouf WE; Hernandez-Medrano JH; Pincott-Allen C; Campbell BK
    Hum Reprod; 2014 Jan; 29(1):146-54. PubMed ID: 24256992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone as a potential agent to slow down ovarian aging.
    Lin LT; Cheng JT; Wang PH; Li CJ; Tsui KH
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1855-1862. PubMed ID: 28892223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.